Found 14 matching trials
Study of the Vascular Effects of Serelaxin
PHASE2This was a mechanistic study in patients with coronary artery disease on th...
Location
Novartis Investigative Site
Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients
PHASE3This was a multinational, multicenter, randomized, open-label study to conf...
Location
Novartis Investigative Site
An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension
PHASE2The main purpose of this exploratory study was to investigate the effect of...
Location
Novartis Investigative Site
PK of Serelaxin in Severe Renal Impairment and ESRD
PHASE1The study is designed to evaluate the pharmacokinetics, safety and tolerabi...
Location
Novartis Investigative Site
Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients
PHASE2This is a multicenter, randomized, double-blind, placebo-controlled study t...
Location
Novartis Investigative Site
Recombinant Human Relaxin for the Treatment of Decompensated CHF
PHASE2Two doses of relaxin will be compared to placebo for the treatment of patie...
Location
Russian Scientific Centre of Surgery n.a. B.V.Petrovsky of Russian Academy of Medical Sciences
Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHF
PHASE3The purpose of the study was to evaluate the efficacy, safety and tolerabil...
Location
Novartis Investigative Site
Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure
PHASE2The purpose of the study was to evaluate the safety, tolerability and pharm...
Location
Novartis Investigative Site
Hemodynamic Responses to RLX030 Infusion in Subjects With Acute Heart Failure
PHASE2This study will assess the hemodynamic effect of RLX030 infusion in subject...
Location
Novartis Investigative Site
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
PHASE3The purpose of the study was to evaluate the efficacy, safety and tolerabil...
Location
Novartis Investigative Site